House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
Background: Allergen-specific immunotherapy is currently the only disease-modifying treatment for allergic asthma, and it has been shown to improve control of asthma while reducing both drug use and asthma exacerbations. However, its effects on lung function-especially its long-term effects-remain c...
Saved in:
Main Authors: | Kazutaka Nogami (Author), Mizuho Nagao (Author), Takafumi Takase (Author), Yasuaki Yasuda (Author), Shingo Yamada (Author), Mayumi Matsunaga (Author), Miyuki Hoshi (Author), Kana Hamada (Author), Yu Kuwabara (Author), Takeshi Tsugawa (Author), Takao Fujisawa (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
by: Yaqi Yang, et al.
Published: (2021) -
Immunotherapy of house dust mite allergy
by: Lin Yang, et al.
Published: (2017) -
Shortening of the Induction Period of Allergic Asthma in Cynomolgus Monkeys by Ascaris suum and House Dust Mite
by: Katsumasa Iwashita, et al.
Published: (2008) -
Climate change and house-dust mite allergy
by: Denis Charpin
Published: (2021) -
Efficacy and safety of subcutaneous immunotherapy in asthmatic children allergic to house dust mite: a meta-analysis and systematic review
by: Chen Zheng, et al.
Published: (2023)